Correlation of the serum concentrations of tumour necrosis factor and nitric oxide with disease severity in chronic Chagas disease (American trypanosomiasis)

Annals of Tropical Medicine and Parasitology

Volumn 101, Issue 2, 2007, Pages 123-132

  Perez Fuentes R ^a,b   Lopez Colombo A ^c   Ordonez Toquero G ^c   Gomez Albino, I ^c   Ramos, J ^a   Torres Rasgado, E ^a   Salgado Rosas, H ^a   Romero Diaz M ^a   Pulido Perez P ^a   Sanchez Guillen M C ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOMEGALY; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; ESOPHAGUS ACHALASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; TRYPANOSOMA CRUZI; CHILD; METABOLISM; MEXICO; MIDDLE AGED;

TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHAGAS DISEASE; CHILD; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; NITRIC OXIDE; TUMOR NECROSIS FACTORS;

EID: 34548155748     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485907X154593     Document Type: Article

References (49)

1. Abrahamsohn, I. A. & Coffman, R. L. (1996). Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Experimental Parasitology, 84, 231-244.
2. Adams, L. B., Hibbs, J. B., Taintor, R. R. & Krahenbuhl, J. L. (1987). Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. Journal of Immunology, 144, 2725-2729.
3. Andrade, Z. A. (1999). Immunopathology of Chagas disease. Memórias do Instituto Oswaldo Cruz, 94 (Suppl. 1), 71-80.
4. Bachmaier,.K., Neu, N., Pummerer, C., Duncan, G.S., Mak, T. W., Matsuyama, T. & Penninger, J. M. (1997). iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation, 96, 585-591.
5. Barbaro, G., Fisher, S. D. & Lipshultz, S. E. (2001). Pathogenesis of HIV-associated cardiovascular complications. Lancet Infectious Diseases, 1, 115-124.
6. Beutler, B. & Grau, G. E. (1993). Tumor necrosis factor in the pathogenesis of infectious diseases. Critical Care Medicine, 21 (Suppl. 10), S423-S435.
7. Bogdan, C., Stenger, S., Rollinghoff, M. & Solbach, W. (1991). Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes. European Journal of Immunology, 21, 327-333.
8. Camargo, M. E., Segura, E. L., Kagan, I. G., Souza, J. M., Carvalheiro, J. D., Yanovsky, J. F. & Guimaraes, M. C. (1986). Three years of collaboration on the standardization of Chagas disease serodiagnosis in the Americas: an appraisal. Bulletin of the Pan American Health Organization, 20, 233-244.
9. Chandra, M., Tanowitz, H. B., Petkova, S. B., Huang, H., Weiss, L. M., Winner, M., Factor, S. M., Shtutin, V., Jelicks, L. A., Chan, J. & Shirani, J. (2002). Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). International Journal for Parasitology, 32, 897-905.
10. Chandrasekar, B., Melby, P. C., Troyer, D. A. & Freeman, G. L. (2000). Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy. Clinical and Experimental Immunology, 121, 112-119.
11. Farrell, A. J., Blake, D. R., Palmer, R. M. & Moncada, S. (1992). Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Annals of the Rheumatic Diseases, 51, 1219-1222.
12. Flesch, I. E. A. & Kaufmann, S. H. E. (1991). Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infection and Immunity, 59, 3213-3218.
13. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schreiber, R., Mak, T. W. & Bloom, B. R. (1995). Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 2, 561-572.
14. Garcia, S. B., Paula, J. S., Giovannetti, G. S., Zenha, F., Ramalho, E. M., Zucoloto, S., Silva, J. S. & Cunha, F. Q. (1999). Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Experimental Parasilology, 93, 191-197.
15. Gazzinelli, R. T., Oswald, I. P., Hieny, S., James, S. L. & Sher, A. (1992). The microbicidal activity of interferon gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. European Journal Immunology, 22, 2501-2506.
16. Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., Muller, W., Trinchieri, G. & Sher, A. (1996). In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Journal of Immunology, 157, 798-805.
17. Gerard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M. & Velu, T. (1993). Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. Journal of Experimental Medicine, 177, 547-550.
18. Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., Vassalli, P., Hommel, M. & Lambert, P. H. (1989). Tumor necrosis factor and disease severity in children with falciparum malaria. New England Journal of Medicine, 320, 586-591.
19. Habib, F. M., Springall, D. R., Davies, G. J., Oakley, C. M., Yacoub, M. H. & Polak, J. M. (1996). Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet, 347, 1151-1155.
20. Havell, E. A. (1989). Evidence that tumor necrosis factor has an important role in antibacterial resistance. Journal of Immunology, 143, 2894-2899.
21. Holscher, C., Kohler, G., Muller, U., Mossmann, H., Schaub, G. A. & Brombacher, F. (1998). Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infection and Immunity, 66, 1208-1215.
22. Holscher, C., Mohrs, M., Dai, W. J., Kohler, G., Ryffel, B., Schaub, G. A., Mossmann, H. & Brombacher, F. (2000). Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infection and Immunity, 68, 4075-4083.
23. Huang, H., Chan, J., Wittner, M., Jelicks, L. A., Morris, S. A., Factor, S. M., Weiss, L. M., Braunstein, V. L., Bacchi, C. J., Yarlett, N., Chandra, M., Shirani, J. & Tanowitz, H. B. (1999). Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. Journal of Molecular and Cellular Cardiology, 31, 75-88.
24. Jungersten, L., Edlund, A., Hafstrom, L. O., Karlsson, L., Petersson, A. S. & Wennmalm, A. (1993). Plasma nitrate as an index of immune system activation in animals and man. Journal of Clinical and Laboratory Immunology, 40, 1-4.
25. Laucella, S. A., Rottenberg, M. E. & de Titto, E. H. (1996). Role of cytokines in resistance and pathology in Trypanosoma cruzi infection. Revista Argentina de Microbiologia, 28, 99-109.
26. Luquetti, A. O. (1999). Evolution of knowledge on the etiological diagnosis of chagasic infection. Memórias do Instituto Oswalde Cruz, 94 (Suppl. 1), 283-284.
27. Macedo, A. M. & Pena, S. D. J. (1998). Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitology Today, 14, 119-124.
28. Machado, F. S., Martins, G. A., Aliberti, J. C., Mestriner, F. L., Cunha, F. Q. & Silva, J.S. (2000). Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation, 102, 3003-3008.
29. Miller, M. J. S., Sadowska-Krowicka, H., Chotinaruemol, S., Kakkis, J. L. & Clark, D. A. (1993). Amelioration of chronic ileitis by nitric oxide synthase inhibition. Journal of Pharmacology and Experimental Therapeutics, 264, 11-16.
30. Moncada, S. (1992). Nitric oxide gas: mediator, modulator, and pathophysiologic entity. Journal of Laboratory and Clinical Medicine, 120, 187-191.
31. Moncayo, A. & Ortiz Yanine, M. I. (2006). An update on Chagas disease (human American trypanosomiasis). Annals of Tropical Medicine and Parasitology, 100, 000-000.
32. Nussler, A. K. & Billiar, T. R. (1993). Inflammation, immunoregulation, and inducible nitric oxide synthase. Journal of Leukocyte Biology, 54, 171-178.
33. Okomo-Assoumou, M. C., Daulouede, S., Lemesre, J. L., N'Zila-Mouanda, A. & Vincendeau, P. (1995). Correlation of high serum levels of tumor necrosis factor-alpha with disease severity in human African trypanosomiasis. American Journal of Tropical Medicine and Hygiene, 53, 539-543.
34. Pérez-Fuentes, R., Sánchez-Guillén, M. C., González-Alvarez, C., Montéon, V. M., Reyes, P. A. & Rosales-Encina, J. L. (1998). Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas disease patients to commercial and autochtonous Trypanosoma cruzi antigen. American Journal of Tropical Medicine and Hygiene, 58, 715-720.
35. Pérez-Fuentes, R., Guégan, J.-F., Barnabé, C., López-Colombo, A., Salgado-Rosas, H., Torres-Rasgado, E., Briones, B., Romero-Díaz, M., Ramos-Jiménez, J. & Sánchez- Guillén, M.C. (2003). Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. International Journal for Parasitology, 33, 293-299.
36. Petray, P., Rottenberg, M. E., Grinstein, S. & Orn, A. (1994). Release of nitric oxide during the experimental infection with Trypanosoma cruzi. Parasite Immunology, 16, 193-199.
37. Prata, A. (2001). Clinical and epidemiological aspects of Chagas disease. Lancet Infection Diseases, 1, 92-100.
38. Roach, D. R., Bean, A. G., Demangel, C., France, M. P., Briscoe, H. & Britton, W. J. (2002). TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. Journal of Immunology, 168, 4620-4627.
39. Rottenberg, M. E., Castanos-Velez, E., de Mesquita, R., Laguardia, O. G., Biberfeld, P. & Orn, A. (1996). Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. European Journal of Immunology, 26, 3203-3213.
40. Saunders, B. M. & Cooper, A. M. (2000). Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunology and Cell Biology, 78, 334-341.
41. Schmidt, H. H., Wilke, P., Evers, B. & Bohme, E. (1989). Enzymatic formation of nitrogen oxides from L-arginine in bovine brain cytosol. Biochemical and Biophysical Research Communications, 165, 284-291.
42. Silva, J. S., Vespa, G. N., Cardoso, M. A., Aliberti, J. C. & Cunha, F. Q. (1995). Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infection and Immunity, 63, 4862-4867.
43. Tracey, K. J. & Cerami, A. (1993). Tumor necrosis factor: an updated review of its biology. Critical Care Medicine, 21 (Suppl. 10), S415-S422.
44. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey III, T. J., Zentella, A. & Albert, J. D. (1986). Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470-474.
45. Truyens, C., Torrico, F., Angelo-Barrios, A., Lucas, R., Heremans, H., de Baetselier, P. & Carlier, Y. (1995). The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. Parasite Immunology, 17, 561-568.
46. Tsujino, M., Hirata, Y., Imai, T., Kanno, K., Eguchi, S., Ito, H. & Marumo, F. (1994). Induction of nitric oxide synthase gene by interleukin-1β in cultured rat cardiocytes. Circulation, 90, 375-383.
47. Vespa, G. N., Cunha, F. Q. & Silva, J. S. (1994). Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infection and Immunity, 62, 5177-5182.
48. Wright, C. E., Rees, D. D. & Moncada, S. (1992). Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovascular Research, 26, 48-57.
49. Zhou, J., Zhao, Q. & Yao, H. (2000). The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions. Zhonghua Jie He He Hu Xi Za Zhi, 23, 158-160.